The OECD and the ESRC Genomics Policy & Research Forum jointly organised a one-day Forum on 12 November 2012 in Paris. The event was both retrospective and forward-looking. The forum concluded that the promise of biotechnology is not set but evolves with fresh scientific knowledge, novel laws and regulations. The future of biotechnology needs to also integrate social and cultural dimensions.
English, Excel, 704kb
The obesity epidemic slowed down in several OECD countries during the past three years. Rates grew less that previously projected, or did not grow at all, according to new data from ten OECD countries. However, rates remain high and social disparities in obesity are unabated.
English, PDF, 416kb
Data from OECD Health Data 2012 focusing on key US issues: why is the US health spending so high? Is US health spending higher due to higher prices or higher service provision? (or both?)? Is the quality of care better in the US? What are the trends in key risk factors to health in the US?
Les dépenses de santé continuent de progresser plus rapidement que la croissance économique dans la plupart des pays de l’OCDE, perpétuant ainsi la tendance observée depuis les années 70, selon la Base de données de l’OCDE sur la santé 2011.
English, Excel, 376kb
The United States spent 16% of its national income (GDP) on health in 2007, which is by far, the highest share in the OECD. This presentation was given by Mark Pearson, Head of OECD Health Division, to the U.S Senate Special Committee on Aging.
This paper derives estimates of the efficiency of welfare spending in Slovenia and the other OECD countries from data envelopment analysis based on model specifications used in earlier OECD studies.
Mental health issues cost the UK around GBP 70 billion every year, or roughly 4.5% of GDP, in lost productivity at work, benefit payments and health care expenditure.